These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8269201)

  • 21. The early phenomena of restenosis following percutaneous transluminal coronary angioplasty.
    Ueda M; Becker AE; Fujimoto T; Tsukada T
    Eur Heart J; 1991 Aug; 12(8):937-45. PubMed ID: 1915432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dipyridamole directly inhibits vascular smooth muscle cell proliferation in vitro and in vivo: implications in the treatment of restenosis after angioplasty.
    Singh JP; Rothfuss KJ; Wiernicki TR; Lacefield WB; Kurtz WL; Brown RF; Brune KA; Bailey D; Dubé GP
    J Am Coll Cardiol; 1994 Mar; 23(3):665-71. PubMed ID: 8113550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cell culture as a prescreening system for drug prevention of restenosis?].
    Voisard R; Dartsch PC; Seitzer U; Roth D; Kochs M; Hombach V
    Vasa Suppl; 1991; 33():140-1. PubMed ID: 1838623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Search for new strategies for prevention of restenosis after angioplasty: the effect of cytostatic drugs on cell migration of re-stenosing human plaque cells in vitro].
    Voisard R; Hamm H; Seitzer U; Dartsch PC; Osterhues H; Kochs M; Hombach V
    Vasa Suppl; 1992; 35():132-3. PubMed ID: 1481017
    [No Abstract]   [Full Text] [Related]  

  • 25. [Restenosed growth of plaque cells from restenosed peripheral and coronary plaque material of the human in vitro: a correlation to animal experiment results following angioplasty].
    Voisard R; Dartsch PC; Seitzer U; Hannekum A; Hombach V; Betz E
    Vasa Suppl; 1991; 33():135-7. PubMed ID: 1838622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Directional atherectomy for treatment of restenosis within coronary stents: clinical, angiographic and histologic results.
    Strauss BH; Umans VA; van Suylen RJ; de Feyter PJ; Marco J; Robertson GC; Renkin J; Heyndrickx G; Vuzevski VD; Bosman FT
    J Am Coll Cardiol; 1992 Dec; 20(7):1465-73. PubMed ID: 1360479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colchicine and antineoplastic therapy for the prevention of restenosis after percutaneous coronary interventions.
    Muller DW; Ellis SG; Topol EJ
    J Am Coll Cardiol; 1991 May; 17(6 Suppl B):126B-131B. PubMed ID: 2016470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colchicine antagonizes the activity of human smooth muscle cells cultivated from arteriosclerotic lesions after atherectomy.
    Bauriedel G; Heimerl J; Beinert T; Welsch U; Höfling B
    Coron Artery Dis; 1994 Jun; 5(6):531-9. PubMed ID: 7952413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Restenosis after coronary angioplasty: its pathogenesis and prevention].
    Marzocchi A; Marrozzini C; Piovaccari G; Fattori R; Castriota F; D'Anniballe G; Branzi A; Magnani B
    Cardiologia; 1991 Dec; 36(12 Suppl 1):309-20. PubMed ID: 1841786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valproic acid inhibits proliferation of human coronary vascular cells (SI/MPL-ratio: 0.5): a novel candidate for systemic and local therapy of postinterventional restenosis.
    Voisard R; Krebs R; Baur R; Hombach V
    Coron Artery Dis; 2010 Aug; 21(5):286-91. PubMed ID: 20508518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different radiosensitivity of smooth muscle cells and endothelial cells in vitro as demonstrated by irradiation from a Re-188 filled balloon catheter.
    Kotzerke J; Gertler R; Buchmann I; Baur R; Hombach V; Norbert Reske S; Voisard R
    Atherosclerosis; 2000 Sep; 152(1):35-42. PubMed ID: 10996337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue characteristics of restenosis after percutaneous transluminal coronary angioplasty in diabetic patients.
    Moreno PR; Fallon JT; Murcia AM; Leon MN; Simosa H; Fuster V; Palacios IF
    J Am Coll Cardiol; 1999 Oct; 34(4):1045-9. PubMed ID: 10520788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serial changes of coronary arteries after percutaneous transluminal coronary angioplasty: histopathological and immunohistochemical study].
    Inoue K; Nakamura N; Kakio T; Suyama H; Tanaka S; Goto Y; Nakazawa Y; Yamamoto Y; Nagamatsu T
    J Cardiol; 1994; 24(4):279-91. PubMed ID: 8057240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of restenosis. A correlation of clinical observations with cellular responses.
    Haudenschild CC
    Z Kardiol; 1990; 79 Suppl 3():17-22. PubMed ID: 2099039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury.
    Ohlstein EH; Douglas SA; Sung CP; Yue TL; Louden C; Arleth A; Poste G; Ruffolo RR; Feuerstein GZ
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6189-93. PubMed ID: 8327499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
    Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro model of the inner parts of a vessel wall with cultured human vascular cells.
    Roth DR; Axel DI; Betz EL
    Coron Artery Dis; 1993 Mar; 4(3):283-91. PubMed ID: 8269223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene therapy for vascular proliferative disorders.
    Chang MW; Leiden JM
    Semin Interv Cardiol; 1996 Sep; 1(3):185-93. PubMed ID: 9552510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human internal mammary artery organ culture model of coronary stenting: a novel investigation of smooth muscle cell response to drug-eluting stents.
    Swanson N; Javed Q; Hogrefe K; Gershlick A
    Clin Sci (Lond); 2002 Oct; 103(4):347-53. PubMed ID: 12241533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cascade model for restenosis. A special case of atherosclerosis progression.
    Libby P; Schwartz D; Brogi E; Tanaka H; Clinton SK
    Circulation; 1992 Dec; 86(6 Suppl):III47-52. PubMed ID: 1424051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.